Hints and tips:
Related Special Reports
...Pharmaceuticals....
...Janssen is the pharmaceutical division of J&J....
...subsidiary Janssen and US drug group Merck....
...Janssen, the pharmaceuticals division of J&J, and Pfizer both started their phase 3 trials in September last year....
...Infectious Diseases Analytics (VIDA) research unit at the University of the Witwatersrand, and chief investigator on the trial in South Africa said: “Recent data from a study in South Africa sponsored by Janssen...
...McKee was a senior executive at Janssen Pharmaceuticals, a division of Johnson & Johnson....
...Najat Khan, chief data science officer and head of R&D strategy at Janssen, the pharmaceuticals arm of Johnson & Johnson, says it is building a bank of “bilingual talent”....
...Not only was the BioNTech/Pfizer vaccine the first to be deployed but it has suffered less from rare side effects and manufacturing glitches than its big western rivals Oxford/AstraZeneca, Janssen or Moderna...
...A booster shot of the Johnson & Johnson Covid-19 vaccine produced a strong and fast antibody response against the virus, the pharmaceutical company said on Wednesday....
...A booster shot of Johnson & Johnson’s Covid-19 vaccine produced a strong and rapid antibody response against the virus, the pharmaceutical company said on Wednesday....
...Medsafe has already approved the Pfizer Covid-19 vaccine for people aged 16 and up, and the Janssen vaccine for those 18 and over. New Zealand also has a purchase agreement for the Novavax vaccine....
...“The Janssen vaccine will be another weapon in our arsenal to beat this pandemic,” said vaccines minister Nadhim Zahawi....
..., J&J’s pharmaceutical division, told the panel on Friday: “Janssen’s vaccine candidate would play a critical role in the global efforts to fight Covid-19 . . ....
...This month Hong Kong-based Insilico Medicine inked a drug discovery deal with Janssen. Bayer recently backed US-based Recursion Pharmaceuticals....
FDA will now weigh whether to allow use of first single-dose jab to prevent the virus
...Despite the wariness, Dr Janssens said he believed the tide will turn among medics after the first round. “I am hopeful then others will follow,” he said....
...“At present, no clear causal relationship has been established between these rare events and the Janssen [J&J] Covid-19 vaccine,” it said, adding that it was working closely with experts and regulators to...
...According to Martin Janssen, chief executive of Zurich-based financial software company Ecofin, Switzerland has to be “allowed to be different”....
...J&J is preparing to test a new formulation that could be targeted at the 501.v2 variant, but Mathai Mammen, global head of research and development for Janssen, J&J’s pharmaceuticals division, said he was...
...That means that non-pharmaceutical interventions such as distancing and masking will be required well into 2021....
...“The acquisition was driven by the significant opportunity seen in nipocalimab, along with the scientific capability Janssen is acquiring with the Momenta team,” J&J said in a statement....
...Through its Janssen subsidiary, the New Jersey-based drugmaker will administer its experimental vaccine to 6,000 UK volunteers in two doses in a phase-3 trial....
...Through its Janssen subsidiary, the New Jersey-based drugmaker will administer its experimental vaccine to 6,000 UK volunteers in two doses in a phase 3 trial....
...Doses of the AstraZeneca vaccine will be supplemented by up to 10m doses of the Pfizer/BioNTech vaccine this year, as well as many more doses of the Janssen and Novavax vaccines in the first half of 2021...
..., J&J’s pharmaceutical division....
International Edition